Laboratory for Regenerative Medicine, University of Cambridge, Cambridge, UK.
Expert Rev Mol Med. 2010 Aug 13;12:25. doi: 10.1017/S1462399410001596.
Following Shinya Yamanaka's first report describing the reprogramming of fibroblasts into stem cells over three years ago, some sceptics initially drew analogies between this new field of research and the quasi-mystical practice of 'alchemy'. Unlike the alchemist, however, stem cell researchers have rigorously tested and repeated experiments, proving their very own brand of cellular 'alchemy' to be a reality, with potentially massive implications for the study of human biology and clinical medicine. These investigations have resulted in an explosion of related publications and initiated the field of stem cell research known as 'induced pluripotency'. In this review, we give an account of the historical development, current technologies and potential clinical applications of induced pluripotency and conclude with a perspective on the possible future directions for this dynamic field.
早在三年前山中伸弥(Shinya Yamanaka)首次报道将成纤维细胞重编程为诱导多能干细胞(iPS 细胞)以来,一些怀疑论者最初将这一新研究领域与神秘的“炼金术”相类比。然而,与炼金术士不同的是,干细胞研究人员已经对实验进行了严格的测试和重复,证明他们自己的细胞“炼金术”是真实存在的,这可能对人类生物学和临床医学的研究产生巨大影响。这些研究导致了相关出版物的大量涌现,并开创了诱导多能干细胞研究领域,即“诱导多能性”。在这篇综述中,我们介绍了诱导多能性的历史发展、当前技术和潜在的临床应用,并对这一充满活力的领域的未来发展方向进行了展望。